Olguin-Albuerne M, Dominguez G, Moran J
Oxid Med Cell Longev. 2014; 2014:678371.
PMID: 25215174
PMC: 4151592.
DOI: 10.1155/2014/678371.
Fracasso P, Williams K, Chen R, Picus J, Ma C, Ellis M
Cancer Chemother Pharmacol. 2010; 67(6):1225-37.
PMID: 20694727
PMC: 3102212.
DOI: 10.1007/s00280-010-1410-1.
Martin-Lopez A, Sanchez-Miron A, Garcia-Camacho F, Contreras-Gomez A, Molina-Grima E
Cytotechnology. 2010; 62(3):205-15.
PMID: 20490659
PMC: 2932903.
DOI: 10.1007/s10616-010-9278-9.
Harmalkar M, Shirsat N
Neurochem Res. 2006; 31(5):685-92.
PMID: 16770740
DOI: 10.1007/s11064-006-9068-0.
Meier B
Protoplasma. 2001; 217(1-3):101-16.
PMID: 11732327
DOI: 10.1007/BF01289419.
Establishment of a tetraploid Meth-A cell line through polyploidization by demecolcine but not by staurosporine, K-252A and paclitaxel.
Fujikawa-Yamamoto K, Wang S, Yamagishi H, Ohdoi C, Murano H, Ikeda T
Cell Prolif. 2001; 34(4):211-22.
PMID: 11529879
PMC: 6496146.
DOI: 10.1046/j.1365-2184.2001.00204.x.
Tryprostatin A, a specific and novel inhibitor of microtubule assembly.
Usui T, Kondoh M, Cui C, Mayumi T, Osada H
Biochem J. 1998; 333 ( Pt 3):543-8.
PMID: 9677311
PMC: 1219615.
DOI: 10.1042/bj3330543.
Uncoupling of the order of the S and M phases: effects of staurosporine on human cell cycle kinases.
Stokke T, Smedshammer L, Jonassen T, Blomhoff H, Skarstad K, Steen H
Cell Prolif. 1997; 30(5):197-218.
PMID: 9420612
PMC: 7081159.
Effects of interferon and PKC modulators on human glioma protein kinase C, cell proliferation, and cell cycle.
Acevedo-Duncan M, Zhang R, Cooper D, Greenberg H
Neurochem Res. 1997; 22(7):775-84.
PMID: 9232628
DOI: 10.1023/a:1022071407268.
Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells.
Courage C, Snowden R, Gescher A
Br J Cancer. 1996; 74(8):1199-205.
PMID: 8883405
PMC: 2075912.
DOI: 10.1038/bjc.1996.517.
Regulation of the salvage pathway of deoxynucleotides synthesis in apoptosis induced by growth factor deprivation.
Oliver F, Collins M, Lopez-Rivas A
Biochem J. 1996; 316 ( Pt 2):421-5.
PMID: 8687383
PMC: 1217367.
DOI: 10.1042/bj3160421.
Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.
Jacobsen M, Weil M, Raff M
J Cell Biol. 1996; 133(5):1041-51.
PMID: 8655577
PMC: 2120856.
DOI: 10.1083/jcb.133.5.1041.
G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.
Schnier J, Nishi K, Goodrich D, Bradbury E
Proc Natl Acad Sci U S A. 1996; 93(12):5941-6.
PMID: 8650198
PMC: 39167.
DOI: 10.1073/pnas.93.12.5941.
Two novel protein kinase C-related genes of fission yeast are essential for cell viability and implicated in cell shape control.
Toda T, Shimanuki M, Yanagida M
EMBO J. 1993; 12(5):1987-95.
PMID: 8491190
PMC: 413420.
DOI: 10.1002/j.1460-2075.1993.tb05848.x.
K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line.
Nakayama T, Hashimoto Y, Kaneko Y, Yoshida M, Beppu T, Ohmi K
Experientia. 1993; 49(10):876-80.
PMID: 8224104
DOI: 10.1007/BF01952601.
Protein kinase inhibitor, staurosporine, prevents okadaic acid- or caffeine-induced chromosome condensation.
Nakamura K, Antoku S
In Vitro Cell Dev Biol Anim. 1993; 29A(10):760-2.
PMID: 8118609
DOI: 10.1007/BF02634341.
A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells.
Nagai M, Yamada H, Nakada S, Ochi K, Nemoto T, Takahara S
Mol Cell Biochem. 1995; 144(2):191-5.
PMID: 7623791
DOI: 10.1007/BF00944399.
Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.
Akinaga S, Nomura K, Gomi K, Okabe M
Cancer Chemother Pharmacol. 1994; 33(4):273-80.
PMID: 7506638
DOI: 10.1007/BF00685899.
Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a.
Usui T, Yoshida M, Abe K, Osada H, Isono K, Beppu T
J Cell Biol. 1991; 115(5):1275-82.
PMID: 1955475
PMC: 2289235.
DOI: 10.1083/jcb.115.5.1275.
Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle.
Crissman H, Gadbois D, Tobey R, Bradbury E
Proc Natl Acad Sci U S A. 1991; 88(17):7580-4.
PMID: 1652754
PMC: 52345.
DOI: 10.1073/pnas.88.17.7580.